[HTML][HTML] The sweet and sour of serological glycoprotein tumor biomarker quantification
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam, EP Diamandis - BMC Medicine, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Aberrant and dysregulated protein
glycosylation is a well-established event in the process of oncogenesis and cancer …
glycosylation is a well-established event in the process of oncogenesis and cancer …
[HTML][HTML] The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam… - BMC …, 2013 - bmcmedicine.biomedcentral.com
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam, EP Diamandis - BMC Medicine, 2013 - go.gale.com
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam… - BMC medicine, 2013 - pubmed.ncbi.nlm.nih.gov
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
[PDF][PDF] The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam, EP Diamandis - 2013 - cyberleninka.org
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
The sweet and sour of serological glycoprotein tumor biomarker quantification.
U Kuzmanov, H Kosanam, EP Diamandis - BMC Medicine, 2013 - search.ebscohost.com
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
The sweet and sour of serological glycoprotein tumor biomarker quantification.
U Kuzmanov, H Kosanam, EP Diamandis - BMC Medicine, 2013 - europepmc.org
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam, EP Diamandis - tspace.library.utoronto.ca
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
[PDF][PDF] The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam, EP Diamandis - 2013 - academia.edu
Aberrant and dysregulated protein glycosylation is a well-established event in the process of
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …
oncogenesis and cancer progression. Years of study on the glycobiology of cancer have …